ADVAIR treats two of the main causes of asthma symptoms—airway constriction and airway inflammation—to help prevent symptoms in the first place. Results may vary. ADVAIR is not used to relieve sudden breathing problems and won't replace a rescue inhaler.
If you are on a long-term asthma control medicine, such as an inhaled corticosteroid, and your symptoms keep coming back, talk to your doctor and find out if ADVAIR may be right for you.
ADVAIR should be used only if your doctor decides that your asthma is not well controlled with a long-term asthma control medicine, such as an inhaled corticosteroid. Once your asthma is well controlled, your doctor will decide if you can stop ADVAIR and may prescribe a different asthma control medicine, like an inhaled corticosteroid.
Your Results May Vary.
ADVAIR DISKUS 250/50 helps significantly improve lung function* so you can breathe better and is clinically proven to help reduce the number of COPD exacerbations in people who have had an exacerbation. Your results may vary. An exacerbation is when your COPD symptoms (including cough, increased mucus production, and shortness of breath) are worse than usual. This can last for a few days or longer and often requires treatment with antibiotics, oral steroids, and, in some cases, hospitalization.
ADVAIR DISKUS contains both an anti-inflammatory medicine (fluticasone propionate†) and a long-acting bronchodilator (salmeterol) working together to help improve your lung function.
COPD is a chronic condition that is always there. That's why it is important to take ADVAIR DISKUS twice a day, every day, to help improve lung function so you can breathe better.* Your results may vary. ADVAIR DISKUS is approved for adults with COPD, including chronic bronchitis, emphysema, or both. ADVAIR DISKUS is not for, and should not be used to treat, sudden symptoms of COPD. ADVAIR DISKUS won't replace a rescue inhaler. You should only take 1 inhalation of ADVAIR DISKUS twice a day. Higher doses will not provide additional benefits.
Ask your doctor if ADVAIR DISKUS is right for you.
ADVAIR HFA is not approved for the treatment of COPD.
People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as salmeterol (one of the medicines in ADVAIR), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD.
ADVAIR, ADVAIR DISKUS, DISKUS and the shape of the DISKUS inhaler are registered trademarks of the GSK group of companies.
The color PURPLE used with inhalers for ADVAIR is a trademark of the GSK group of companies.